SynthesisFrontiers in oncology2021

Efficacy and Safety of Lenalidomide Monotherapy for Relapsed/Refractory Diffuse Large B Cell Lymphoma: Systematic Review and Meta-Analysis.

Jia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.